luzindole has been researched along with 2,2'-azino-di-(3-ethylbenzothiazoline)-6-sulfonic acid in 1 studies
Studies (luzindole) | Trials (luzindole) | Recent Studies (post-2010) (luzindole) | Studies (2,2'-azino-di-(3-ethylbenzothiazoline)-6-sulfonic acid) | Trials (2,2'-azino-di-(3-ethylbenzothiazoline)-6-sulfonic acid) | Recent Studies (post-2010) (2,2'-azino-di-(3-ethylbenzothiazoline)-6-sulfonic acid) |
---|---|---|---|---|---|
265 | 1 | 119 | 1,625 | 4 | 1,083 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Mathes, AM; Rensing, H; Wolf, B | 1 |
1 other study(ies) available for luzindole and 2,2'-azino-di-(3-ethylbenzothiazoline)-6-sulfonic acid
Article | Year |
---|---|
Melatonin receptor antagonist luzindole is a powerful radical scavenger in vitro.
Topics: Benzothiazoles; Free Radical Scavengers; Free Radicals; Humans; Receptors, Melatonin; Sulfonic Acids; Tryptamines | 2008 |